Biohaven Income Statement (2021-2026) | BHVN

Income Statement Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter) 46.97M41.82M70.10M177.09M52.84M4.25M63.46M79.49M95.52M134.81M155.97M314.82M157.61M167.47M187.58M15.00M141.17M12.00M103.83M
Selling, General & Administrative (Quarter) 8.52M9.06M19.68M20.02M14.79M76.37M14.32M14.52M15.03M18.90M27.27M18.95M20.56M22.46M33.98M27.33M28.21M20.79M26.60M
Other Operating Expenses (Quarter) 132.80M169.37M109.94M
Operating Expenses (Quarter) 55.49M50.88M89.77M197.11M67.64M213.41M77.78M94.01M110.55M153.71M183.24M333.77M178.17M189.93M221.56M211.70M169.38M142.73M130.43M
Operating Income (Quarter) -55.49M-50.88M-89.77M-197.11M-67.64M-213.41M-77.78M-94.01M-110.55M-153.71M-183.24M-333.77M-178.17M-189.93M-221.56M-211.70M-169.38M-142.73M-130.43M
EBIT (Quarter) -55.49M-50.88M-89.77M-197.11M-67.64M-213.41M-77.78M-94.01M-110.55M-153.71M-183.24M-333.77M-178.17M-189.93M-221.56M-211.70M-169.38M-142.73M-130.43M
Non-operating items
Other Non Operating Income (Quarter) -0.01M1.45M-0.00M-0.07M-1.84M8.23M5.84M4.69M7.74M4.30M
Non Operating Income (Quarter) -0.01M1.45M-0.00M-0.07M-1.84M8.23M5.84M4.69M7.74M4.30M14.18M17.80M3.14M0.49M13.81M-3.84M-2.47M0.17M
Net income details
EBT (Quarter) -55.50M-49.43M-89.78M-197.18M-67.64M-215.25M-69.55M-88.17M-105.86M-145.97M-178.94M-319.59M-160.36M-186.79M-221.07M-197.89M-173.22M-145.20M-130.26M
Tax Provisions (Quarter) -1.13M2.46M7.25M6.11M1.22M-14.14M0.94M2.18M-3.29M-1.21M0.57M0.18M-0.06M0.05M0.61M0.26M0.22M0.35M0.27M
Profit After Tax (Quarter) -54.37M-51.89M-97.03M-203.29M-68.85M-201.11M-70.49M-90.35M-102.57M-144.76M-179.50M-319.77M-160.30M-186.84M-221.68M-198.15M-173.44M-145.56M-130.53M
Income from Continuing Operations (Quarter) -54.37M-51.89M-97.03M-203.29M-68.85M-201.11M-70.49M-90.35M-102.57M-144.76M-179.50M-319.77M-160.30M-186.84M-221.68M-198.15M-173.44M-145.56M-130.53M
Consolidated Net Income (Quarter) -54.37M-51.89M-97.03M-203.29M-68.85M-201.11M-70.49M-90.35M-102.57M-144.76M-179.50M-319.77M-160.30M-186.84M-221.68M-198.15M-173.44M-145.56M-130.53M
Income towards Parent Company (Quarter) -54.37M-51.89M-97.03M-203.29M-68.85M-201.11M-70.49M-90.35M-102.57M-144.76M-179.50M-319.77M-160.30M-186.84M-221.68M-198.15M-173.44M-145.56M-130.53M
Net Income towards Common Stockholders (Quarter) -54.37M-51.89M-97.03M-203.29M-68.85M-201.11M-70.49M-90.35M-102.57M-144.76M-179.50M-319.77M-160.30M-186.84M-221.68M-198.15M-173.44M-145.56M-130.53M
Additional items
EPS (Basic) (Quarter) -1.38-1.32-2.46-5.16-1.75-3.37-1.03-1.32-1.50-1.87-2.20-3.64-1.70-1.78-2.17-1.94-1.64-1.12-0.88
EPS (Weighted Average and Diluted) (Quarter) -1.38-1.32-2.46-5.16-1.75-3.37-1.03-1.32-1.50-1.87-2.20-3.64-1.70-1.78-2.17-1.94-1.64-1.12-0.88
Shares Outstanding (Weighted Average) (Quarter) 39.37M39.38M39.38M39.38M39.38M44.74M68.21M68.23M68.32M71.20M81.60M87.77M94.37M91.23M101.94M102.16M105.82M107.62M147.62M
Shares Outstanding (Diluted Average) (Quarter) 39.37M39.38M39.38M39.38M39.38M44.74M68.21M68.25M68.26M71.20M81.60M87.77M94.37M91.23M101.94M102.16M103.39M107.62M147.62M
EBITDA (Quarter) -54.37M-50.88M-97.03M-203.29M-68.85M-213.41M-70.61M-90.49M-102.44M-153.71M-179.54M-319.74M-160.09M-189.93M-221.68M-198.22M-173.40M-142.73M-130.58M
Tax Rate (Quarter) 2.04%-4.97%-8.08%-3.10%-1.80%6.57%-1.35%-2.47%3.11%0.83%-0.32%-0.06%0.04%-0.03%-0.28%-0.13%-0.13%-0.24%-0.21%